| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/09/2009 | EP1379270B1 Use of anti-cd3 monoclonal antibodies and il-5 for treating autoimmune diseases |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | EP1279735B1 Malaria plasmodium antigen polypeptide se36, method of purifying the same and vaccine and diagnostic with the use of the thus obtained antigen |
| 09/09/2009 | EP1165096B1 Use of cytidine derivatives for the treatment of leukaemia |
| 09/09/2009 | EP1002068B1 Mutations in the myostatin gene cause double-muscling in mammals |
| 09/09/2009 | EP0996857B1 Cancer associated nucleic acids and polypeptides |
| 09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/09/2009 | EP0771147B1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/09/2009 | CN101528259A Human antibodies that bind cxcr4 and uses thereof |
| 09/09/2009 | CN101528258A A pharmaceutical composition for treating lung cancer, a method for inhibiting growth or invasion of lung cancer and a method for treating lung cancer |
| 09/09/2009 | CN101528257A Antibodies that bind cxcr7 epitopes |
| 09/09/2009 | CN101528256A Use of an anti-CD151 antibody in the treatment of cancer |
| 09/09/2009 | CN101528255A HPV antigen fusion protein vaccine compositions and uses thereof |
| 09/09/2009 | CN101528254A Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins |
| 09/09/2009 | CN101525602A Polypeptide for preparing anti-PINK1 polyclonal antiserum and application thereof |
| 09/09/2009 | CN101525597A New hepatitis A inactivated vaccine virus strain and method for culturing same |
| 09/09/2009 | CN101525385A Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases |
| 09/09/2009 | CN101525384A A bispecific antibody and the making method and the application thereof |
| 09/09/2009 | CN101525378A Listonella anguillarum subunit vaccine antigenic protein and application thereof |
| 09/09/2009 | CN101524539A New application of rabies human immunoglobulin in preparing medicine for preventing and controlling Japanese encephalitis and combined vaccine for rabies and Japanese encephalitis |
| 09/09/2009 | CN101524538A Influenza-pandemic influenza bivalent combined vaccine and preparation method thereof |
| 09/09/2009 | CN101524537A Influenza oral tablet vaccine, influenza oral slow-release vaccine and preparation methods thereof |
| 09/09/2009 | CN101524536A Japanese encephalitis vaccine prepared by human embryonic lung fibroblasts and preparation method thereof |
| 09/09/2009 | CN101524535A Capsular polysaccharide solubilisation and combination vaccines |
| 09/09/2009 | CN101524534A Capsular polysaccharide solubilisation and combination vaccines |
| 09/09/2009 | CN101524533A Capsular polysaccharide solubilisation and combination vaccines |
| 09/09/2009 | CN101524532A Single dose of a mycoplasma hyopneumoniae vaccine |
| 09/09/2009 | CN100537773C Modified vaccinia ankara virus variant |
| 09/09/2009 | CN100537770C Von willebrand factor (vWF)-cleaving enzyme |
| 09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
| 09/09/2009 | CN100536918C Mixture with dust mite for treating allergy |
| 09/09/2009 | CN100536917C Cow mastitis concatenate inactivated vaccine |
| 09/09/2009 | CN100536836C Materials and methods for preventing and treating microbe-mediated epithelial disorders |
| 09/08/2009 | US7585953 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 09/08/2009 | US7585952 Fully human miniantibody (scFv) called Erbicin, specific for the receptor ErbB2; antitumor; transmembrane tyrosine kinase receptor |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585942 Vascular Leak Syndrome; polypeptide toxophore from a DT; has cytotoxicity comparable to that of a DT molecule |
| 09/08/2009 | US7585847 Immunostimulatory nucleic acids for the treatment of asthma and allergy |
| 09/08/2009 | US7585835 GASP1: a follistatin domain containing protein |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585669 Genetic vaccine comprising an expression vector encoding a Streptococcus pneumoniae pneumolysin polypeptide that lacks hemolytic activity |
| 09/08/2009 | US7585658 Staphylococcus aureus antigenic polypeptides and compositions |
| 09/08/2009 | US7585657 Methods of using the signal to transmit and maintain influenza viral and foreign nucleic acid in virus and cells; hemagglutinin (HA) and neuraminidase (NA). |
| 09/08/2009 | US7585648 Nucleotide sequences coding myostatin epitopes for use in treatment and prevention of diabetic disorders; immunotherapy |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585621 Detection of West Nile virus infection and vaccination |
| 09/08/2009 | US7585619 Method for detecting human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) activity |
| 09/08/2009 | US7585522 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 09/08/2009 | US7585519 Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 09/08/2009 | US7585512 Composition and method of using tumor cells |
| 09/08/2009 | US7585511 Apolipoprotein L-I and/or derivated polypeptide for the treatment of and/or the prevention of diseases induced by trypanosoma |
| 09/08/2009 | US7585510 Use of the hypo3 gene, or homologue thereof, in the production of an Neisseria strain for the assessment, treatment or prevention of Neisseria infection; treatment of septicaemia and meningitis caused by Neisseria meningitidis |
| 09/08/2009 | US7585509 Erb-2 receptor targeting peptide |
| 09/08/2009 | US7585508 Has affinity for and binding capability to red blood cells; NH2-CD4-GBP130-COOH; AIDS and HIV |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585506 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/08/2009 | US7585505 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer |
| 09/08/2009 | US7585504 For inhibiting the release of a proinflammatory cytokine from a vertebrate cell; sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury |
| 09/08/2009 | US7585503 Method for detecting multi-drug resistance |
| 09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
| 09/08/2009 | US7585501 Compositions and methods for treating kidney disease |
| 09/08/2009 | US7585500 Fully human monoclonal antibodies to IL-13 |
| 09/08/2009 | CA2555911C Adjuvant compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
| 09/08/2009 | CA2361887C Method of using anti-phospholipase a2 antibodies to enhance growth or improve feed efficiency |
| 09/08/2009 | CA2355466C Multi-component vaccine comprising at least two antigens from haemophilus influenzae |
| 09/08/2009 | CA2352777C Preparations containing virus-like particles as immunopotentiators administered through the mucosa |
| 09/08/2009 | CA2294701C Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 09/08/2009 | CA2252604C Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 09/08/2009 | CA2224074C System and method for producing drug-loaded microparticles |
| 09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 09/03/2009 | WO2009108932A2 Selectin ligands useful in the diagnosis and treatment of cancer |
| 09/03/2009 | WO2009108807A1 Glycopeptides and methods of making and using them |
| 09/03/2009 | WO2009108738A2 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 09/03/2009 | WO2009108686A1 Composition comprising protein-liposome complex for iontophoresis |
| 09/03/2009 | WO2009108652A1 Antibodies to clostridium difficile spores and uses thereof |
| 09/03/2009 | WO2009108372A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 09/03/2009 | WO2009108360A2 Inhibition of post-radiation tumor growth |
| 09/03/2009 | WO2009108252A2 Method for stimulating immune response against moraxella catarrhalis |
| 09/03/2009 | WO2009108153A1 Methods and compositions for the regulation of lectin complement pathway (lcp)- associated complement activation in hyperglycemic myocardial damage |
| 09/03/2009 | WO2009107147A2 Multizone walk through metal detector with camera & text overlay chip for measuring, displaying, transferring data with video and recording the parameters of the system synchronized with the video image in computer |
| 09/03/2009 | WO2009106773A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof |
| 09/03/2009 | WO2009106532A2 Use of prokaryotic tir-domain containing proteins as therapeutic and diagnostic agents |
| 09/03/2009 | WO2009106356A1 Monoclonal antibodies against the rgm a protein and uses thereof |
| 09/03/2009 | WO2009106085A1 Vaccine compositions comprising saccharide antigens |
| 09/03/2009 | WO2009105934A1 Monoclonal antibody anti-human rankl |
| 09/03/2009 | WO2009092038A8 Influenza dna vaccination and methods of use thereof |
| 09/03/2009 | WO2009081276A3 Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom |
| 09/03/2009 | WO2009076317A3 Activated t cells |
| 09/03/2009 | WO2009073905A8 Method for increasing immunoreactivity |
| 09/03/2009 | WO2009071696A3 Humanized antibody molecules specific for il-31 |
| 09/03/2009 | WO2009065561A3 System for delivery into a xcr1 positive cell and uses thereof |
| 09/03/2009 | WO2009061996A3 Antibodies that bind human dendritic and epithelial cell 205 (dec-205) |
| 09/03/2009 | WO2009055669A3 Monoclonal antibodies against activated and unactivated protein c |
| 09/03/2009 | WO2009048537A3 Humanized antibody |
| 09/03/2009 | WO2009039229A3 Method of conferring a protective immune response to norovirus |
| 09/03/2009 | WO2009017689A3 Methods for detection and prevention of tick infestation and pathogen transmission |
| 09/03/2009 | WO2009001219A3 Immunocytokines for cancer treatment in combination with chemotherapeutic agents |
| 09/03/2009 | WO2008127391A3 Antigen-antibody complexes as hiv-1 vaccines |